OPTIMIZERx Corp
NASDAQ:OPRX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.14
21.68
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
OPTIMIZERx Corp
OptimizeRx Corp. is digital health company, engaging in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Rochester, Michigan and currently employs 97 full-time employees. The company went IPO on 2005-05-18. The firm enables engagement between life sciences organizations, healthcare providers and patients. The company connects approximately 60% of United States healthcare providers and their patients through a technology platform embedded within its own point-of-care network. The firm principal solutions and applications include financial messaging, brand therapeutic support messaging, and brand support. Its financial messaging enables doctors and staffs to access a universe of sample voucher, co-pay coupons and other patient support option through their electronic medical records (EMR) and/or e-prescribe system. Its brand messaging service includes brands awareness message, reminder advertisement, therapeutic support and unbranded messages. Its brand support is focused on educating and working with pharmaceuticals manufacturer on identifying, formulation and implementing new eRx media strategy for promoting their solutions.
OptimizeRx Corp. is digital health company, engaging in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Rochester, Michigan and currently employs 97 full-time employees. The company went IPO on 2005-05-18. The firm enables engagement between life sciences organizations, healthcare providers and patients. The company connects approximately 60% of United States healthcare providers and their patients through a technology platform embedded within its own point-of-care network. The firm principal solutions and applications include financial messaging, brand therapeutic support messaging, and brand support. Its financial messaging enables doctors and staffs to access a universe of sample voucher, co-pay coupons and other patient support option through their electronic medical records (EMR) and/or e-prescribe system. Its brand messaging service includes brands awareness message, reminder advertisement, therapeutic support and unbranded messages. Its brand support is focused on educating and working with pharmaceuticals manufacturer on identifying, formulation and implementing new eRx media strategy for promoting their solutions.
Visibility & Guidance: Management emphasized improved visibility into future revenues thanks to a shift toward more predictable, contracted revenue models, allowing them to provide guidance out to 2026.
Revenue Smoothing: The shift away from periodic or lumpy revenue and toward renewable, subscription-like revenues has made quarterly revenues more consistent and predictable.
Conservative Guidance: Guidance for the remainder of the year and 2026 is based only on contracted revenues, with no contributions assumed from potential pipeline deals or the new Lamar partnership.
Gross Margin Expansion: Gross margin increased in the third quarter, driven by favorable product and channel partner mix, as well as growth in higher-margin platform businesses.
RFP & Client Demand: Both DTC and HCP client demand remain healthy, with stronger RFP activity and an improving win rate due to better-targeted offerings.
Mid-Tier Client Growth: There is notable growth in mid-tier clients, attributed to the company’s technology enabling these clients to compete more effectively.
Operating Expenses: Operating expenses stayed stable, with increases tied mostly to variable compensation from overperformance, and management expects a steady run rate moving forward.